Yokoyama et al identified risk factors for venous thromboembolism in Japanese patients with diffuse large B-cell lymphoma (DLBCL). These can help to identify a patient who may benefit from interventions to reduce thromboembolic risk. The authors are from Keio University and Waseda University in Tokyo.